BICO 2.0, our updated strategy, will launch into the world on September 17! Tune in to the online portion of the Capital Markets Day and be among the first to learn more. Register here: https://lnkd.in/dFDR8eAN #BICO #Strategy2.0 #CMD2024 #LabAutomation
Om oss
BICO is a leading provider of life science solutions and laboratory automation that enable more efficient development of new treatments with more specificity and less need for animal testing. The company uses bioconvergence as its operating system, combining advanced technologies with biology to streamline and automate workflows within the pharmaceutical and biopharma industries. With 32,000+ instruments installed in over 65 countries, BICO products and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 11,000 publications. Operating through three business areas – Bioprinting, Biosciences and Bioautomation – the BICO Group strives towards the long-term ambition of enabling the reduction the world’s organ shortage and speeding up drug development to create the future of life-saving treatments. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO.
- Webbplats
-
http://www.bico.com
Extern länk för BICO
- Bransch
- Forskning inom bioteknik
- Företagsstorlek
- 1 001–5 000 anställda
- Huvudkontor
- Kallebäck, Västra Götaland County
- Typ
- Publikt aktiebolag
- Specialistområden
- 3D Bioprinting, Bioprinting, Bioink, Biomedicine, Biotechnology, Biotech, Biomaterials, 3D printing, Stem cell research, Regenerative medicine, medicine, Medical research, R&D och Bioprinting research
Adresser
Anställda på BICO
Uppdateringar
-
The BICO Group Q2 2024 interim report is live! Tune into the earnings call at 10 a.m. CEST presented by CEO and President Maria Forss and CFO Jacob Thordenberg with updates and comments of the development in the BICO Group. The report, link to earnings call, and presentations are available here: www.bico.com/investors
-
Welcome to BICO’s Capital Markets Day on September 17, 2024! Tune in for the launch of the Group’s updated strategy 2.0 and take a deep dive into the field of lab automation. Register via this link: https://lnkd.in/dFDR8eAN. #BICO #Strategy2.0 #CMD2024 #LabAutomation
-
-
Andreas Joersjö has been appointed as General Counsel, and we look forward to welcoming him to our Executive Management. Andréas will join BICO by mid-October at the latest. Read the press release: https://lnkd.in/dKmqNz6Z
-
BICO Group company MatTek Life Sciences just announced an exciting collaboration with Charles River Laboratories!
ICYMI: MatTek, in collaboration with Charles River Laboratories has been awarded a grant from the Foundation for Chemistry Research & Initiatives to advance non-animal research. The program will develop a new approach method (NAM) for inhalation toxicology. As leaders in the field of human tissue engineering, and the creators of EpiAirway, MatTek is uniquely qualified to lend its expertise to the project. “This partnership marks a pivotal moment where innovation and collaboration will lead us toward safer and more reliable outcomes for all," said MatTek CEO Alex Armento. Read more: https://bit.ly/3z8QLrK #betterscience #NAMs
-
-
Welcome Anders Fogelberg, BICO’s new Chief Commercial Officer Today we are thrilled to welcome Anders Fogelberg as our Chief Commercial Officer. Commercial excellence has been defined as one of our top strategic priorities and Anders will be pivotal in setting and driving the strategy towards that target, i.e., in scaling the BICO business, increasing the commercialization efforts of the portfolio and further explore opportunities for collaborations and partnerships. Join us in welcoming Anders to the BICO family! #welcometotheteam #CCO #newCCO #executivemanagement #BICO #commercialexcellence
-
The BIONOVA X from CELLINK is the world's first digital light processing (DLP) 3D bioprinter that can handle such a wide variety of biomaterials and living cells. It enables effortless modeling of microarchitecture, vasculature, and complex geometries directly onto multi-well plates. Printing directly in standardized microwell plates eliminates the need for manual sample transfers, allowing long-term cell culturing and live cell imaging to occur in the same plate. These plates are easily transferable to automated instruments like DISPENDIX’s I.DOT liquid handler and Discover Echo Inc.’s CELLCYTE X imaging system. 🔍 Curious about DLP bioprinting? This technology uses light to create highly precise 3D structures, making it a revolutionary tool for tissue engineering, drug testing, and regenerative medicine. Watch the video below to see DLP bioprinting in action and learn how the BIONOVA X is transforming the future of bioprinting. #3Dbioprinting #regenerativemedicine #drugtesting #3Dcellculture #DLP #biotechnology
-
What an incredible week it's been! From SLAS (Society for Laboratory Automation and Screening) to the World Biomaterial Congress, we've had the privilege of witnessing remarkable advancements in biomaterials research and lab automation. 🤖🔬 Connecting with so many passionate and talented individuals from the life science community has been truly inspiring. We're grateful for the opportunity to share our latest innovations and to learn from the amazing work of others. 🌟 Looking forward to meeting you all again soon! CELLINK, CYTENA, Biosero, Cellenion, QINSTRUMENTS
-
-
🔬Join us as we showcase cutting-edge technologies from the BICO group at SLAS (Society for Laboratory Automation and Screening) in Barcelona, Spain. 🚀 Our mission is to drive the bioconvergence revolution by offering the life science community groundbreaking tools and services that usher in a new era of efficiency and accelerate the development of life saving treatments. 🌟Stop by to explore the latest innovations and connect with industry leaders. We look forward to seeing you there! #labautomation #SLAS #LaboftheFuture #lifescience #bioconvergence CYTENA, Cellenion, QINSTRUMENTS, Biosero
-
-
Our colleagues at Discover Echo Inc. are starting a great initiative to positively impact life science and support the Women in Cell Biology (WICB) group, part of the American Society for Cell Biology (ASCB). The company has partnered with Moody Haus to bring you Repose—a soothing candle designed to help you unwind after a challenging day in research or academia. 10% of the proceeds from Repose will go to WICB. WICB offers vital career support and advice for all cell biologists, with a special focus on issues that disproportionately affect women. They provide invaluable resources like workshops, networking opportunities, and career development. Discover how Repose can enhance your relaxation ritual while making a difference in the scientific community: https://moody.haus/repose
-